Posts Tagged cancer

Rochester biologists show how a selfish genetic element called retrotransposons that can cause tumors may also trigger the death of cancer cells.

A Wilmot Cancer Institute study of more than 90 families and caregivers looked for common threads about their loved one’s final transition from active treatment to death and dying.

According to a University of Rochester Medical Center study, men with advanced cancer are 30 percent less likely than women to consider palliative care, and may view palliative options as a sign of “giving up.”

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study led by the Medical Center.

Rochester biologists were surprised to see that despite its remarkable longevity, the naked mole rat still has cells that undergo senescence, like the cells in much shorter-lived mice.

Some Wilmot Cancer Institute patients with advanced melanoma may have longer disease-free survival thanks to new drug treatment options tested by Rochester researchers.

Wilmot Cancer Institute scientists have discovered that a three-drug combination can simultaneously target the cancer cells as well as the other harmful, inflammatory cells within the tumor.

Chemo-brain, or cancer-related cognitive impairment, is estimated to impact 80 percent of people in treatment. A new Medical Center study shows that inflammation in the blood plays a key role.

A pathway that enables embryonic cells to develop into different organs can be reactivated by cancer cells. A cyclic peptide has been found that can block the activation of this pathway, and is also less likely to trigger resistance in cancer cells.

A Medical Center team recently received a $3.8 million grant to continue their investigation of an innovative technology that could lead to preventative treatments for radiation damage in patients.